production might be increased in membranes with higher amounts of unsaturated fatty acids.
Acute myocardial injury in pediatric cardiovascular surgery is a major problem that is not found to the same extent in adult cardiovascular surgery, 2, 5 possibly because the free radical scavenging system of the myocardium in patients with cyanotic CHD may not neutralize the superoxide ion radicals that are formed by a sudden increase in arterial oxygen tension or by reperfusion after ischemic arrest. 2, 5, 7 Oxygen-mediated reperfusion injury is caused by the production of oxygen free radicals generated by the rapid reintroduction of oxygen. 5 Although previous experimental studies have shown that initiating either cardiopulmonary bypass at a lower fraction of inspired oxygen 8 or leukocyte filtration may decrease free radical injury, 5 effective pharmacotherapy to prevent the acceleration of lipid peroxidation during the ischemic reperfusion stage of pediatric cardiovascular surgery has not been sufficiently examined. Carnitine is a vital component in lipid metabolism for the production of adenosine triphosphate through -oxidation and subsequent oxidative phosphorylation. L-carnitine (LCAR) can suppress lipid peroxidation after ischemia reperfusion; [9] [10] [11] however, there have been few studies showing the effect of LCAR in cyanotic CHD models, and no study has examined the effects of LCAR therapy on cardiac fatty acid composition.
The purpose of this study was to evaluate fatty acid composition and lipid peroxidation in the immature hypoxic myocardium, and to determine the effect of hypoxia on the myocardial antioxidant system. The present model is a close relation to cyanotic CHD after repair. As previous studies have demonstrated that hypoxic alterations reach a level of steady-state by 2 weeks, 12 we believe this time period of hypoxia can be used to generate an experimental model that effectively reflects cyanotic CHD. An additional goal was to elucidate the effect of LCAR on the composition of fatty acids, antioxidants, and the concentration of carnitine in the hypoxic myocardium.
Methods

Animal Preparation and Treatment
Four-week-old male Sprague-Dawley rats were purchased from Shimizu laboratory supplies (Kyoto, Japan). The total number of rats required for the various groups used in this study was 75. The rats were exposed to 10% oxygen in a mixture of nitrogen and room air in a chamber for 2 weeks ("Hypoxia") (n=28). 13 Half of them were then exposed to 100% oxygen for 12 h (+O2). The O2 concentration in the chamber was monitored by an analyzer. Five rats were reared in each condition using a 12-h light -dark cycle. The chamber was opened twice a week for a few minutes to clean the cages. Control age-matched normoxic rats were maintained in room air for the same time period ("Normoxia") (n=14). Standard rat chow (CRF-1; Charles River, Yokohama, Japan) and water were provided ad libitum. LCAR (200 mg/kg) was administered by intraperitoneal injection daily for 2 weeks to a group of rats in the hypoxic chamber (+ LCAR) (n=7 per group). During the injection, the mouth of the rat was covered with a mask that delivered 10% oxygen. Vehicle (0.9% NaCl) was injected into the rats by intraperitoneal injection daily (n=5).
At the time of death, the rats were sedated with sodium pentobarbital (50 mg/kg), intubated, and ventilated automatically with 10% oxygen. The heart was removed into normoxic-cooled (4°C) saline; the ascending aorta was cannulated and the heart was flushed with ice-cold saline to remove any blood in the coronary arteries. The heart was dissected from other tissue and weighed. It is well known that chronic hypoxia alters the pulmonary hemodynamics and leads to pulmonary hypertension, with selective hypertrophy of the right ventricle. We analyzed the left ventricle to exclude the influence of pulmonary hypertension. The heart weight was assessed by measurement of the weight of the right ventricular free wall and septum plus the weight of the left ventricular (LV) free wall. The LVs were frozen in liquid nitrogen and stored at -80°C until analysis.
The protocol was reviewed by the Committee of Ethics on Animal Experiments, Kyoto Prefectural University Graduate School of Medicine, and was carried out in accordance with the Guidelines for Animal Experiments, Kyoto Prefectural University of Medicine. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Quantitative Fatty Acid Analysis
Total fatty acids were extracted from tissue samples according to the Bligh-Dyer method. 14 In brief, the LV tissue was extracted with methanol/chloroform/water (2:1:0.8 by volume). After centrifugation, a biphasic system was produced by dilution of the extract with chloroform and saline solution (1:1 by vol.). The lower layer was withdrawn. Individual phospholipid classes were separated by thin layer chromatography. 15 The fatty acid and phospholipid fractions were methylated using 5% hydrogen chloride-methanol at 100°C for 1 h. Butylated hydroxy toluene (0.05 g/L) was added to the methanol to prevent peroxidation of the fatty acids during methylation. Heptadecanoic acid was added to the lipid extract as an internal standard. The fatty acid methyl esters were then analyzed using a Shimadzu gas chromatograph (QP5000) and mass spectrometer (GC17A), equipped with a 30 m×0.25 mm DB-23 column that was coated with (50% cyanopropyl)-methylpolysiloxane (J&W Scientific, Folsom, CA, USA).
Electrospray ionization mass spectrometry (ESI-MS) was used to elucidate the structure of the phospholipids. The lipids were extracted from the rat ventricles by BlighDyer's method. 13 The ESI-MS analysis was performed using a 4000Q TRAP quadropole-linear ion trap hybrid mass spectrometer (Applied Biosystems/MDS Sciex, Concord, ON, Canada) with a LC-10AD VPu HPLC system combined with a SIL-10AD VP autosampler (Shimadzu, Kyoto, Japan).
The conditions used for the 4000Q TRAP were as follows. The mobile phase composition was acetonitrile/methanol/ water (6:7:2) containing 0.1% ammonium formate (pH 7.4). The flow rate was 8 l/min. The collision energy used varied according to the desired experiment. Typically, 5 l of the sample was used. Mass spectra of phosphatidylethanolamines (PEs) were detected by a fatty-acyl survey. The molecules including 16:0 and 18:0 were detected by precursor ion scanning of m/z 255.2 and m/z 283.2 in the negative ion mode.
Biochemical Assays
The determination of thiobarbituric acid reactive-substances (TBARs) in the heart was performed according to a modified method of Ohkawa. 16 The absorbance was measured at 532 nm. The 1,1,3,3-tetramethoxypropane was used as an external standard and the level of lipid peroxidation was expressed as mol of malondialdehyde (MDA) per 2.5 mg of tissue protein. Superoxide dismutase (SOD) activity in rat LVs was measured using the SOD Assay Kit -WST (Dojindo Molecular Technologies, Gaithersburg, MD, USA). Catalase activity in rat LVs was measured using a catalase assay kit (No. 707002) (Cayman Chemical, Ann Arbor, MI, USA). Glutathione peroxidase (GPx) activity in rat LVs was measured using a GPx assay kit (No. 03102) (Cayman Chemical).
Carnitine Concentration in Rat LVs
Carnitine concentrations were measured using the technique of Millington et al. 17 In brief, LV tissue (10-15 mg) was homogenized with 1.5 ml of Krebs-Henseleit solution. Following homogenization, 0.1 ml of this homogenized solution, 0.05 ml of the internal standard (Labeled carnitine standards SET B. Cambridge Isotope Laboratories, Andover, MA, USA) and 0.9 ml of methanol were vortexed and centrifuged at 200 Hz for 10 min. The resulting supernatant was dried under nitrogen. The residue was methylated by 5% hydrogen chloride in methanol and heated at 65°C for 15 min. Methanol was then evaporated under a stream of nitrogen and the residue was reconstituted with 20 l of 50% glycerol in methanol containing 1% octylsulfate. A triple stage quadruple mass spectrometer, QUATTRO (Micromass, Manchester, UK), was used with an ion gun of cesium iodide as a secondary ion mass ionization mode. Predominant daughter ions of both labeled and unlabeled standards were m/z 117 for free carnitine, and, m/z 99 for acylcarnitines.
Statistical Analysis
Results are presented as the mean ±the standard deviation. Statistical significance between more than 2 groups was tested using 1-way ANOVA followed by multiple comparisons with a Scheffé test. Student's t-test was used to compare mean values between 2 groups. Differences were considered to be statistically significant at a p-value <0.05.
Results
Weight Parameters
Hypoxia significantly decreased the body weight of the rats, and increased the ratio of heart weight to body weight as compared with the age-matched normoxic controls ( Table 1 ). The latter effect was mainly because of right ventricular hypertrophy derived from enhanced pulmonary vascular resistance under hypoxic conditions. Thus, the ratio of right ventricular free wall weight to body weight showed a marked increase in hypoxic animals (170% of the values for the normoxic rats). However, the ratio of LV free wall plus septum weight to body weight in the "Hypoxia" group did not change significantly compared with the "Normoxia" group.
Total Fatty Acids and Phospholipid Analysis
The fatty acid composition of total and individual phospholipid species is documented in Tables 2-4 . Fig 1 illus- trates the effect of hypoxia on the distribution of the main fatty acids classes in the total and individual phospholipids.
Concentrations of total fatty acids in the LV myocardium in the "Hypoxia" and "Normoxia" groups are summarized in Table 2 and Fig 1. Saturated fatty acids (SFA) accounted for approximately 32% of the total fatty acids in normoxic ventricles, with n-6 polyunsaturated fatty acids (PUFA) and n-3 PUFA accounting for approximately 43% and 18% of total fatty acids, respectively. Hypoxia decreased the proportion of n-6 PUFA, particularly linoleic acid (C18:2), which was accompanied by a proportional increase in n-3 Values are expressed as %mol ± standard deviation. In the total phospholipids and PE, the proportions of n-6 PUFA were decreased and those of n-3 PUFA were increased by hypoxia. This fatty acid profile was unchanged by the addition of l-carnitine (LCAR) and 12-h exposure of hyperoxia. The proportion of n-3 PUFA in PC was low and there was no remarkable change in either n-3 or n-6 PUFA level. *p<0.05 vs Normoxia, n=7 for each group. PUFA, polyunsaturated fatty acid.
PUFA, particularly docosahexaenoic acid (C22:6, DHA). This fatty acid profile was unchanged with the addition of LCAR (Fig 1) . The distribution of fatty acids in PE is presented in Table 3 and Fig 1. SFA accounted for approximately 30% of PE fatty acid, n-6 PUFA for approximately 36%, and n-3 PUFA for approximately 27% in normoxic ventricles. Similar to what was observed for total fatty acids, hypoxia decreased n-6 PUFA and increased n-3 PUFA. The effect was also pronounced with the addition of LCAR (Fig 1) .
The fatty acid composition of phosphatidylcholine (PC) in the LV is shown in Table 4 and Fig 1. SFA accounted for approximately 46% of PC fatty acid, n-6 PUFA for approximately 37%, and n-3 PUFA for approximately 6% in normoxic ventricles. The proportion of n-3 PUFA in PC was low and there was no remarkable change in either n-6 or n-3 PUFA (Fig 1) .
ESI-MS elucidated the fatty acid composition of the total fatty acids and phospholipids. In general, the fatty acid forms in the sn1 position of phospholipid were SFA and fatty acids at the sn2 position were PUFA. The main fatty acids in phospholipids were palmitic acid (C16:0), stearic acid (C18:0), linoleic acid (C18:2), arachidonic acid (C20:4) and DHA (C22:6). The change in C20:4 in the "Hypoxia" group was not remarkable. The conceivable combinations were C16:0-C18:2 (C34:2), C16:0-C22:6 (C38:6), C18:0-C18:2 (C36:2), and C18:0-C22:6 (C40:6). The structure of PE is shown in Fig 2. C34:2 (C16:0-C18:2) and C36:2 (C18:0-C18:2) levels were lower in the "Hypoxia" group compared with the "Normoxia" group. In contrast, C38:6 (C16:0-C22:6) and C40:6 (C18:0-C22:6) were higher in the "Hypoxia" group compared with the levels in the "Normoxia" group.
TBARs Measurement
The MDA levels in the "Normoxia", "Hypoxia", "Normoxia+O2" and "Hypoxia + O2" groups were 1.9±0.7, 1.4±0.7, 2.2±0.6, and 6.3±2.3 mol/2.5-mg protein, respectively. MDA levels were not increased in the "Hypoxia" group compared with the levels in the "Normoxia" group (p=0.75), but were elevated in the "Hypoxia + O2" group compared with the "Normoxia + O2" group (p<0.01) (Fig 3A) . The administration of LCAR to the "Hypoxia + O2" group almost completely suppressed the increased cardiac lipid peroxidation that was observed in only the "Hypoxia + O2 + saline" group (2.6±2.0 mol/2.5-mg protein vs 4.9±0.8 mol/ 2.5-mg protein, p<0.05) (Fig 3B) .
Level of Antioxidants
Tissue SOD activity in the "Hypoxia" group was significantly decreased compared with the activity in the "Normoxia" group (89.7±2.6% vs 94.9±1.4%, p<0.01). Following the administration of LCAR, SOD activity did not change ("Hypoxia + LCAR" 88.8±2.6% vs "Normoxia + LCAR" 94.8±3.4%, p<0.01). Catalase activity and GPx activity were not different between the "Normoxia" and "Hypoxia" groups (Catalase: "Normoxia" 5.6±1.1 nmol/kg dry weight/min; "Hypoxia" 6.4±1.5 nmol/kg dry weight/min, p=0.053, GPx: "Normoxia" 0.57±0.1 mol·min -1 ·mg dry weight -1 , "Hypoxia" 0.45±0.1 mol·min -1 ·mg dry weight -1 , p=0.09). Following the administration of LCAR, catalase activity and GPx activity did not change (Catalase: "Normoxia + LCAR" 5.3±1.3nmol·kg dry weight -1 ·min -1 , and "Hypoxia+LCAR" 5.4±1.1 nmol· kg dry weight -1 ·min -1 , GPx: "Normoxia + LCAR" 0.43±0.1 mol·min -1 ·mg dry weight -1 , and "Hypoxia + LCAR" 0.46±0.1 mol·min -1 ·mg dry weight -1 ).
Cardiac Carnitine Concentrations
Administration of LCAR significantly increased the acetylcarnitine (C2) concentration in both the "Normoxia" and "Hypoxia" groups ( Table 5 ). The free carnitine concentration in the heart tissue did not differ between the "Normoxia" and "Hypoxia" groups. The amount of free carnitine, acetylcarnitine (C2), propionylcarnitine (C3), C4-, and C5-acylcarnitine was also not different between the "Normoxia" and "Hypoxia" groups. 4 
Discussion
We show that exposure of young rats to 2 weeks of hypoxia caused changes in the fatty acid composition and scavenger enzyme activity in the heart. Of importance is the age of the rats. One reason for using 4-week-old rats is the difference in mortality rates we observed with age. In preliminary studies, we exposed male rats immediately at birth to hypoxia for 2 weeks, but the survival rate was quite low, whereas the mortality rate is under 5% for the 4-weekold rats. The impact of nutrition on lipid metabolism is also important because fatty acid composition is greatly influenced by meal composition. 18 The fatty acid composition did not change in the hypoxic rat heart immediately after birth (SFA: "Normoxia" 48.5±2.9%mol, "Hypoxia" 47.0±2.3, p= 0.85; MFA: "Normoxia" 4.3±0.5, "Hypoxia" 5.8±0.5, p< 0.01; n-6 PUFA: "Normoxia" 34.6±0.9, "Hypoxia" 33.8± 1.4, p=0.12; n-3 PUFA: "Normoxia" 12.6±1.7, "Hypoxia" 13.4±2.1, p=0.77). Mammals must obtain fatty acids with more than 2 double bonds (=PUFA) from the diet because they cannot synthesize them. Rats before weaning get PUFA from the dam's milk in which the proportion of PUFA in total fat is less than 20%. After weaning, rats obtain PUFA from chow containing more than 60% of PUFA in the total fat content. From the clinical point of view, this dramatic change in the dietary PUFA supply influences the myocardial fatty acid composition and may be associated with myocardial injury by lipid peroxidation. Because this external effect of a different diet will complicate the consideration of myocardial fatty acid composition, we avoided the nutritional shift from breastfeeding to standard chow during this study. The fatty acid composition in the heart gradually changes during growth; the composition of n-3 PUFA decreases and that of n-6 PUFA increases after weaning. 18 Based on those reports, we selected the starting point of hypoxic exposure as 4 weeks of age, just after weaning.
Two-week-hypoxia decreases cardiac n-6 PUFA content in the young rat, which was mainly attributable to a decrease in C18:2. There was also a concomitant increase in n-3 PUFA, which was mainly related to C22:6 in total lipids and PE. This finding is similar to previous reports of the fatty acid composition of cardiac phospholipids in membrane lipids in adolescents animals exposed to high doses of catecholamines, 19 aortic constriction 20 or intermittent high altitude hypoxia. 21 Although exposure to chronic hypoxia is initially associated with an increase in adrenergic activity, 22 ,23 adrenoceptor blockade does not attenuate the changes in the fatty acid composition of phospholipids. 20 In our preliminary study, the fatty acid composition of hypoxic rat hearts followed by 2 weeks ofnormoxia was not remarkably different in the comparison with that of normoxic rat hearts (data not shown). We believe from these results that the change in fatty acid composition after 2 weeks of hypoxic exposure is reversible by re-establishing a normoxic environment. It has been reported that the proportion of n-3 PUFA in rat heart PE is high, while the proportion in PC is low. 18 However, the different roles of these 2 major phospholipids in cell membranes is not well known.
Recent studies suggest that the contribution of fatty acids to energy metabolism in the LV is unaffected by chronic hypoxic acclimatization. Adrogue et al reported chronic hypobaric hypoxia (45 kPA-11% ambient O2, for a period of 4, 10, and 12 weeks) induced changes in metabolic gene expression, suggesting a downregulation of fatty acid metabolism and an increase in glucose metabolism in the Table 2 .
right ventricle, while LV metabolic gene expression suggested a restoration of fatty acid metabolism. 24 Thus, fatty acid metabolism may not have altered in our model of invivo hypoxia. When we consider the pathology of cyanotic CHD, we enumerate 2 factors. One is the influence of the pressure-and volume-loads, and the second is the influence of hypoxia on the heart. We believe our experimental model allows investigation of the direct effects of hypoxia on LV fatty acid composition; however, as the LVSW/BW (LVSW: LV free wall plus septum weight, BW; body weight) is not altered by hypoxia, the experimental model is unable to assess the contribution of alterations in pressure-and/or volume load. We also observed whether 2 weeks of hypoxia caused a decrease in scavenger enzyme activity in young rat hearts, compared with normoxic hearts. Rapid scavenging of superoxide (O2-) radicals by SOD, catalase and GPx activity prevents these extremely reactive products from attacking other molecules in the cell. As a result, decreased scavenging enzyme activity caused by ischemia or chronic hypoxia may render cells more susceptible to re-oxygenation injury. In the present study, hypoxia decreased myocardial SOD activity, but no change was observed in the tissue catalase or GPx activity. A decrease of SOD by hypoxia conforms to observations in other studies. 7, 25 Our data also demonstrate that lipid peroxidation in the heart is only accelerated with hyperoxia after exposure to chronic hypoxia. Barrington et al have shown that free radicals are unlikely to be a major cause of mechanical dysfunction in reperfused hearts, because no increase in lipid peroxidation occurred during the reperfusion period. 26 The failure of ischemia -reperfusion to increase lipid peroxidation is consistent with the absence of MDA increase during ischemia -reperfusion. 27 The O2-radical has the potential to react with any molecule, and it may lead to lipid peroxidation with the formation of a diene bond. This process can be propagated within the cell membrane until arrested by other scavenger systems. Hypoxia per se does not raise the myocardial lipid peroxidation level, as shown in both our and other studies. 28, 29 Ihnken et al reported that hypoxia increases cardiac susceptibility to oxidant damage by reducing antioxidants, and re-oxygenation further depletes the antioxidant level and accelerates lipid peroxidation. 28 Lipid peroxidation occurs by oxidation of PUFA in microsomal phospholipids. Our results suggest that increased lipid peroxidation by hyperoxia in hypoxic rat hearts may be related to an increase in PUFA content, which has more double bonds and is therefore more susceptible to lipid peroxidation. In chronically hypoxic rats, a shift in favor of n-3 PUFA and a decrease in the level of antioxidants might be necessary to accelerate lipid peroxidation following acute exposure to oxygen. Although MDA was increased in the hypoxia + O2 group (Fig 3A) , there were no differences in the fatty acid composition between the hypoxia and hypoxia + O2 groups (Fig 1) , possibly because of lipid peroxidation occurring in specific subcellular compartments (eg, mitochondria), 30 and thus having been underrepresented in the extracts of LV tissue used in this study. Alternatively, it may be because of differences in the rate of formation of n-3 PUFAs (from n-6 PUFAs) and the rate of formation of MDA.
Several reports have suggested that carnitine derivatives act as free radical scavengers. [9] [10] [11] In support of this, we showed that carnitine effectively scavenges superoxide anions, resulting in inhibition of lipid peroxidation. Our study results revealed that daily addition of LCAR increased the acetylcarnitine concentration in rat hearts. Recent reports show that acetylcarnitine 9 and propionyl carnitine 10, 11 possess potent antioxidant activity. The free radical scavenging activity of acylcarnitine has been shown to be dosedependent. [9] [10] [11] 31 The increase in tissue acetyl carnitine concentration induced by LCAR administration may effectively prevent lipid peroxidation. Although LCAR reduced the levels of lipid hydroperoxide in the heart after oxidative stress, the antioxidant effects of LCAR and its relationship with the composition of membrane lipid bilayers remain to be clarified. In the present study, phospholipid composition remained unchanged in the presence of LCAR in both the "Normoxia" and "Hypoxia" groups. Moreover, LCAR did not affect SOD activity, catalase concentration or GPx activity. Reznick et al have shown that LCAR suppresses hydroxyl radical production in the Fenton reaction. 10 Furthermore, LCAR inhibited xanthine oxidase activity, thus acting as a free radical scavenger and stabilizer of cell membranes. 32 
Experimental Limitations
Potential limitations of this study are as follows.
(1) Children with cyanotic congenital heart defects are generally in a hypoxic condition after birth and are not exposed to normoxia until repair of their congenital heart abnormalities. Thus, our animal model did not exactly mimic the clinical setting because the rats were 4 weeks old before exposure to hypoxia. However, as discussed, it is hard to use neonatal hypoxic models because the mortality rate is high. We selected a hypoxic period of 2 weeks, as this time period has been characterized and well established in adult rat hearts. 12 Specifically, the previous report indicates that various parameters affected by hypoxia reach a steady-state level over this time period. 12 In our preliminary study, 2 days of inhalation hypoxia did not influence cardiac fatty acid composition (data not shown). In the present study, we have used this model of hypoxia to study alterations in cardiac fatty acid composition in the juvenile rat heart.
(2) Body weight of the hypoxic model was significantly different from that of the normoxic model, which is a similar result to that of another report. 13 Hypoxia is associated with an increase in adrenergic activity, 20, 21 which may be responsible for the reduction in body weight.
In conclusion, the present study shows that an increase in n-3 PUFA and a decrease in antioxidants occurs in young rat hearts under chronic hypoxia, which may augment lipid peroxidation following acute exposure to oxygen. LCAR administration increases the acetylcarnitine concentration in hypoxic heart tissue and suppresses the increase in lipid peroxidation following re-oxygenation, despite the lack of an effect on the fatty acid composition and antioxidant levels.
